Latest Headlines

• 

  Alnylam Pharmaceuticals Earnings: Here’s Why Investors are Excited Now

  Derek Hoffman   | Mon, May 6 |  Comment
• 

  Jim Cramer: Buy ConAgra, Kimco Realty, and These 2 Stocks

  Alex Capel   | Thu, Apr 4 |  Comment
• 

  KeyCorp Downgraded to Sell and 3 Downgraded Stocks to Follow

  Alex Capel   | Mon, Feb 11 |  Comment
• 

  BSD Medical Shares Pop, Isis Receives Payment From Alnylam: Healthcare Business Wrap

  Mark Lawson   | Tue, Oct 23 |  Comment
• 

  Healthcare Business Update: Merck Pays Milestone to Ligand, Alnylam Partners with Genzyme

  Mark Lawson   | Mon, Oct 22 |  Comment
• 

  Healthcare Business Recap: Vivus Director BUYS Its Shares, Humana's New INITIATIVE

  Mark Lawson   | Thu, Aug 23 |  Comment
• 

  Healthcare Business Recap: Onyx's Drug Gets APPROVED, Somaxon DIVESTS Shares

  Mark Lawson   | Fri, Jul 20 |  Comment
• 

  Biogen ENTERS into Research Collaboration and 4 Stocks Hitting 52-Week Highs

  Leah Powell   | Wed, Jul 18 |  Comment
• 

  Alnylam Pharmaceuticals Target RAISED and 1 Stock Analysis to Notice Now

  Leah Powell   | Tue, Jul 17 |  Comment
• 

  Authentec CHOSEN for Android Security and 4 Stocks Enjoying 52-Week Highs

  Mark Lawson   | Tue, Jul 17 |  Comment
• 

  Healthcare Review: Alnylam Shoots The MOON, Glaxo ACQUIRES Human Genome

  Mark Lawson   | Mon, Jul 16 |  Comment
• 

  Applied Materials Target REDUCED and 4 Must-See New Analysis Ratings

  Mark Lawson   | Wed, Jul 11 |  Comment